Crinol 2011;9:124 7. Cemgil Arikan D, Aral M, Coskun A, Ozer A. Plasma IL-4, IL-8, IL-12, interferon-g and CRP levels in pregnant females with preeclampsia, and their relation with severity of disease and fetal birth weight. J Matern Fetal Neonatal Med 2012;25: 1569573 eight. Montagnana M, Lippi G, Albiero A, Salvagno GL, Franchi M, Guidi GC. Serum pro-inflammatory cytokines in physiological and pre-eclamptic pregnancies. Gynecol Endocrinol 2008;24: 11316 9. Jonsson Y, Rub M, Matthiesen L, et al. Cytokine mapping of sera from females with preeclampsia and normal pregnancies. J Reprod Immunol 2006;70: 831 10. Carty DM, Anderson LA, Freeman DJ, et al. Early pregnancy soluble E-selectin concentrations and threat of preeclampsia. J Hypertens 2012;30:9542060 DIABETES CARE, VOLUME 36, JULY11. Clausen T, Djurovic S, Brosstad FR, Berg K, Henriksen T. Altered circulating levels of adhesion molecules at 18 weeks’ gestation amongst ladies with eventual preeclampsia: indicators of disturbed placentation in absence of proof of endothelial dysfunction Am J Obstet Gynecol 2000;182:321325 12.Lasalocid sodium Kronborg CS, Gjedsted J, Vittinghus E, Hansen TK, Allen J, Knudsen UB.Nirsevimab Longitudinal measurement of cytokines in pre-eclamptic and normotensive pregnancies. Acta Obstet Gynecol Scand 2011; 90:79196 13. Clausen P, Ekbom P, Damm P, et al. Signs of maternal vascular dysfunction precede preeclampsia in females with sort 1 diabetes. J Diabetes Complications 2007;21: 28893 14. Yu Y, Jenkins AJ, Nankervis AJ, et al. Antiangiogenic aspects and pre-eclampsia in type 1 diabetic females. Diabetologia 2009; 52:16068 15.PMID:25558565 Azar M, Basu A, Jenkins AJ, et al. Serum carotenoids and fat-soluble vitamins in ladies with form 1 diabetes and preeclampsia: a longitudinal study. Diabetes Care 2011;34:1258264 16. Basu A, Alaupovic P, Wu M, et al. Plasma lipoproteins and preeclampsia in girls with variety 1 diabetes: a prospective study. J Clin Endocrinol Metab 2012;97:17521762 17. Jenkins AJ, Rothen M, Klein RL, et al.; DCCT/EDIC Study Group. Crosssectional associations of C-reactive protein with vascular threat aspects and vascular complications inside the DCCT/ EDIC cohort. J Diabetes Complications 2008;22:15363 18. Alex P, Szodoray P, Knowlton N, et al. Multiplex serum cytokine monitoring as a prognostic tool in rheumatoid arthritis. Clin Exp Rheumatol 2007;25: 58492 19. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and danger of creating peripheral vascular illness. Circulation 1998;97:42528 20. Emerging Risk Aspects Collaboration; Kaptoge S, Di Angelantonio E, Pennells L, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012;367:1310320 21. Sesso HD, Buring JE, Rifai N, Blake GJ, Gaziano JM, Ridker PM. C-reactive protein and also the danger of establishing hypertension. JAMA 2003;290:2945951 22. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the prospective role of inflammation. Obstet Gynecol 2001;98: 75762 23. Qiu C, Luthy DA, Zhang C, Walsh SW, Leisenring WM, Williams MA. A potential study of maternal serum C-reactive24.25.26. 27.28.29.30.31.32.33.34.35.protein concentrations and threat of preeclampsia. Am J Hypertens 2004;17:154160 Loukovaara S, Immonen I, Koistinen R, Hiilesmaa V, Kaaja R. Inflammatory markers and retinopathy in pregnancies complex with form I diabetes. Eye (Lond) 2005;19:42230 Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. Inducible expression of vascular.